"Liver-gut" axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease

被引：8
作者：
Guo, Kangxiao [1 ]
Xu, Sisheng [1 ]
Zeng, Zhaofeng [1 ]
机构：
[1] Changsha Hlth Vocat Coll, Changsha, Hunan, Peoples R China
来源：
FRONTIERS IN ENDOCRINOLOGY | 2022年 / 13卷
关键词：
liver-gut" axis; intestinal microorganisms; traditional Chinese medicine; NAFLD; target; MICROBIOTA; ANTIBIOTICS; FIBROSIS; GENES; ACIDS; MICE;
D O I：
10.3389/fendo.2022.1050709
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Non-alcoholic fatty liver disease (NAFLD) occurs when fat accumulates in the liver even without excessive alcohol intake. Among the current therapeutic approaches for NAFLD, lifestyle modification with dietary changes and regular exercise is the mainstay treatment. With the rise of intestinal microecology, regulation of the "liver-gut" axis can be an effective treatment for NAFLD. This review aimed to assess the modulation of the liver-gut microbiota axis with traditional Chinese medicine (TCM) as a therapeutic approach to NAFLD and further explored its application in the newly discovered therapeutic avenues beyond NAFLD treatment.
引用
收藏
页数：9
相关论文
共 63 条
[1]   The gut-liver axis in liver disease: Pathophysiological basis for therapy [J].
Albillos, Agustin ;
de Gottardi, Andrea ;
Rescigno, Maria .
JOURNAL OF HEPATOLOGY, 2020, 72 (03) :558-577
[2]   Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma [J].
Anastasopoulos, Nikolaos-Andreas T. ;
Lianos, Georgios D. ;
Tatsi, Vera ;
Karampa, Anastasia ;
Goussia, Anna ;
Glantzounis, Georgios K. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 14 (11) :1025-1033
[3]   The Natural Course of Non-Alcoholic Fatty Liver Disease [J].
Bertot, Luis Calzadilla ;
Adams, Leon Anton .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
[4]   Implication of Gut Microbiota in Nonalcoholic Fatty Liver Disease [J].
Boursier, Jerome ;
Diehl, Anna Mae .
PLOS PATHOGENS, 2015, 11 (01) :1-6
[5]   Gut- liver axis at the frontier of host-microbial interactions [J].
Brandl, Katharina ;
Kumar, Vipin ;
Eckmann, Lars .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2017, 312 (05) :G413-G419
[6]   Gut microbial metabolites in obesity, NAFLD and T2DM [J].
Canfora, Emanuel E. ;
Meex, Ruth C. R. ;
Venema, Koen ;
Blaak, Ellen E. .
NATURE REVIEWS ENDOCRINOLOGY, 2019, 15 (05) :261-273
[7]   Microbiota-Liver Axis in Hepatic Disease [J].
Chassaing, Benoit ;
Etienne-Mesmin, Lucie ;
Gewirtz, Andrew T. .
HEPATOLOGY, 2014, 59 (01) :328-339
[8]   Antibiotics in early life alter the murine colonic microbiome and adiposity [J].
Cho, Ilseung ;
Yamanishi, Shingo ;
Cox, Laura ;
Methe, Barbara A. ;
Zavadil, Jiri ;
Li, Kelvin ;
Gao, Zhan ;
Mahana, Douglas ;
Raju, Kartik ;
Teitler, Isabel ;
Li, Huilin ;
Alekseyenko, Alexander V. ;
Blaser, Martin J. .
NATURE, 2012, 488 (7413) :621-+
[9]  
Cui X, 2017, MECH LIPID BENEFICIA
[10]   The role of short-chain fatty acids in microbiota-gut-brain communication [J].
Dalile, Boushra ;
Van Oudenhove, Lukas ;
Vervliet, Bram ;
Verbeke, Kristin .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2019, 16 (08) :461-478
1234567